Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis
<p>Abstract</p> <p>Background</p> <p>The development of an effective vaccine against visceral leishmaniasis (VL) caused by <it>Leishmania donovani </it>is an essential aim for controlling the disease. Use of the right adjuvant is of fundamental importance in vaccine formulations for generation of ef...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2010-06-01
|
| Edice: | BMC Microbiology |
| On-line přístup: | http://www.biomedcentral.com/1471-2180/10/181 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|